Meanwhile, it is urgent to develop cartilage-targeted delivery systems to enhance the bioavailability of drugs in the joint cavity and their specific binding ability to chondrocytes, while avoiding potential interference with the homeostasis of the gut microbiota
For example, one study reported ~5.9 kg weight change with oral vs 6.5 kg with injectable at 6 months (in a diabetic population) difference not statistically significant in that dataset
High-dose actives such as protein, fiber, and creatine need volume, which points to powders and drinks
This dose is typically reserved for those who respond to tirzepatide but have not reached their target weight at 10mg after adequate time
BCKDHB partners with ALPI in the cluster 1a in Figure 5A, but the ALPI partner in cluster 4e of Figure 5B is BCKDHA
These drug delivery systems possess improved in-vitro release and pharmacokinetics than conventional dosage forms and topical drug delivery systems [113,114,115,116]